477 related articles for article (PubMed ID: 17198719)
1. Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy.
Hammoudi-Triki D; Lefort J; Rougeot C; Robbe-Vincent A; Bon C; Laraba-Djebari F; Choumet V
Toxicol Appl Pharmacol; 2007 Feb; 218(3):205-14. PubMed ID: 17198719
[TBL] [Abstract][Full Text] [Related]
2. Combination of two antibody fragments F(ab')(2)/Fab: an alternative for scorpion envenoming treatment.
Sami-Merah S; Hammoudi-Triki D; Martin-Eauclaire MF; Laraba-Djebari F
Int Immunopharmacol; 2008 Oct; 8(10):1386-94. PubMed ID: 18687300
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy.
Krifi MN; Savin S; Debray M; Bon C; El Ayeb M; Choumet V
Toxicon; 2005 Feb; 45(2):187-98. PubMed ID: 15626368
[TBL] [Abstract][Full Text] [Related]
4. Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue.
Padilla A; Govezensky T; Possani LD; Larralde C
Toxicon; 2005 Aug; 46(2):142-9. PubMed ID: 15946719
[TBL] [Abstract][Full Text] [Related]
5. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy.
Rivière G; Choumet V; Audebert F; Sabouraud A; Debray M; Scherrmann JM; Bon C
J Pharmacol Exp Ther; 1997 Apr; 281(1):1-8. PubMed ID: 9103473
[TBL] [Abstract][Full Text] [Related]
6. [Application of ELISA for the quantification of Androctonus australis hector venom in the envenomed serum of people and rats before and after immunotherapy].
Hammoudi-Triki D; Laraba-Djebari F
Bull Soc Pathol Exot; 2003 Nov; 96(4):297-301. PubMed ID: 14717046
[TBL] [Abstract][Full Text] [Related]
7. Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab')2 extrusion mechanism from blood to tissues.
Sevcik C; D'Suze G; Díaz P; Salazar V; Hidalgo C; Azpúrua H; Bracho N
Toxicon; 2004 Dec; 44(7):731-41. PubMed ID: 15500849
[TBL] [Abstract][Full Text] [Related]
8. Absorption and elimination of viper venom after antivenom administration.
Rivière G; Choumet V; Saliou B; Debray M; Bon C
J Pharmacol Exp Ther; 1998 May; 285(2):490-5. PubMed ID: 9580588
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
[TBL] [Abstract][Full Text] [Related]
10. Antivenom for critically ill children with neurotoxicity from scorpion stings.
Boyer LV; Theodorou AA; Berg RA; Mallie J; ; Chávez-Méndez A; García-Ubbelohde W; Hardiman S; Alagón A
N Engl J Med; 2009 May; 360(20):2090-8. PubMed ID: 19439743
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a F(ab')2 scorpion antivenom administered intramuscularly in healthy human volunteers.
Vázquez H; Chávez-Haro A; García-Ubbelohde W; Paniagua-Solís J; Alagón A; Sevcik C
Int Immunopharmacol; 2010 Nov; 10(11):1318-24. PubMed ID: 20849955
[TBL] [Abstract][Full Text] [Related]
12. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms.
Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A
Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058
[TBL] [Abstract][Full Text] [Related]
13. Initial volume of a drug before it reaches the volume of distribution: pharmacokinetics of F(ab')2 antivenoms and other drugs.
Sevcik C; Salazar V; Díaz P; D'Suze G
Toxicon; 2007 Oct; 50(5):653-65. PubMed ID: 17689580
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a F(ab')2 scorpion antivenom in healthy human volunteers.
Vázquez H; Chávez-Haro A; García-Ubbelohde W; Mancilla-Nava R; Paniagua-Solís J; Alagón A; Sevcik C
Toxicon; 2005 Dec; 46(7):797-805. PubMed ID: 16197974
[TBL] [Abstract][Full Text] [Related]
15. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom.
León G; Stiles B; Alape A; Rojas G; Gutiérrez JM
Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of cardio-respiratory perturbations following Mesobuthus eupeus envenomation in anesthetized rabbits with commercial polyvalent F(ab')2 antivenom.
Zayerzadeh E; Koohi MK; Mirakabadi AZ; Fardipoor A; Kassaian SE; Rabbani S; Anvari MS
Toxicon; 2012 Feb; 59(2):249-56. PubMed ID: 22118980
[TBL] [Abstract][Full Text] [Related]
17. Intravenous
Kurtović T; Karabuva S; Grenc D; Dobaja Borak M; Križaj I; Lukšić B; Halassy B; Brvar M
Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919927
[No Abstract] [Full Text] [Related]
18. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM
Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538
[TBL] [Abstract][Full Text] [Related]
19. [Recombinant antibodies: a new application in scorpion envenomation?].
Muzard J; Billiald P; Goyffon M; Aubrey N
Bull Soc Pathol Exot; 2005 Dec; 98(5):383-5. PubMed ID: 16425719
[TBL] [Abstract][Full Text] [Related]
20. The neutralizing capacity of Androctonus crassicauda antivenom against Mesobuthus eupeus scorpion venom.
Ozkan O; Carhan A
Toxicon; 2008 Aug; 52(2):375-9. PubMed ID: 18625264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
